AVTR-PA - Avantor, Inc.

NYSE - NYSE Delayed Price. Currency in USD
64.85
-0.32 (-0.49%)
At close: 11:37AM EST
Stock chart is not supported by your current browser
Previous Close65.17
Open65.14
Bid0.00 x 800
Ask0.00 x 800
Day's Range64.85 - 65.14
52 Week Range49.68 - 67.45
Volume20,916
Avg. Volume104,136
Market Cap10.66B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield3.12 (4.73%)
Ex-Dividend DateJan 28, 2020
1y Target EstN/A
All
News
Press Releases
  • PR Newswire

    Avantor® Declares Dividend on Mandatory Convertible Preferred Stock

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on February 15, 2020 to holders of record on February 1, 2020.

  • PR Newswire

    Avantor® to Participate in the J.P. Morgan Healthcare Conference

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield, President and Chief Executive Officer, and Tom Szlosek, Executive Vice President, Chief Financial Officer, will participate in the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California. Mr. Stubblefield is scheduled to present on Tuesday, January 14, 2020 at 4:30 p.m. (PT). The live webcast can be accessed on the Investors section of the company's website at www.avantorsciences.com.

  • Avantor® Opens Innovation and Customer Support Center in Shanghai to Boost Biopharmaceutical Innovation in China
    PR Newswire

    Avantor® Opens Innovation and Customer Support Center in Shanghai to Boost Biopharmaceutical Innovation in China

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today opened an innovation and customer support center in Shanghai, China to support biopharma research and technology development in the region. Avantor now has nine innovation centers worldwide.

  • PR Newswire

    Avantor® Announces Closing of Initial Public Offering and Concurrent Offering of Mandatory Convertible Preferred Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

    RADNOR, Pa. , May 21, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, ...